pharmaphorum

MARCH 10, 2021

The study suggests that serum taken from patients injected with the mRNA shot, also known as BNT162b2, was able to neutralise a genetically engineered version of SARS-CoV-2 with the P.1 1 mutations, as well as variants from the UK and South Africa.

Vaccination 58

Vaccination Vaccine Genetic Engineering Engineer 58

The Pharma Data

JUNE 1, 2022

Scientists who have long studied this molecule’s functions in bacterial infections traced development of extensive lung damage in infected mice to heightened levels of the enzyme triggered by the invading SARS-CoV-2 virus. They used a version of the SARS-CoV-2 virus that other scientists have engineered specifically to cause disease in mice.

Immune Response 52

Immune Response Genetic Engineering Engineer Research 52

Cloudbyz

MARCH 5, 2024

Biologics: Biologics are large, complex molecules, often proteins, that are produced using living cells. Mode of Action : Small Molecules: They often work by binding to specific sites on target proteins to inhibit or activate their function, which can affect various biological pathways inside the cell.

Development 75

Development Drugs Manufacturing Immune Response 75

Drug Discovery World

NOVEMBER 17, 2022

The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape. Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. . Designer cells .

Bacteria 52

Bacteria Engineer Gene Genetics 52

Drug Discovery World

MAY 25, 2023

Advances like genetically engineered mouse models (GEMMs), patient-derived xenografts (PDXs) and organoids are allowing the integration of mouse models with human cohorts. However, she has identified FFA4, a G protein-coupled receptor (GCPR) with the therapeutic potential to improve insulin sensitivity in metabolic disorders.

Research 52

Research Drugs In-Vitro Insulin 52

Drug Discovery World

NOVEMBER 8, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting.

Antibody 64

Antibody Engineer Protein Scientist 64

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

FEBRUARY 3, 2023

One of these candidates is VSV-SUDV, developed and tested by scientists at NIH’s National Institute of Allergy and Infectious Diseases in Hamilton, Montana. In the current studies, the investigators replaced the key EBOV protein in Ervebo with the comparable protein from SUDV.

Vaccination 52

Vaccination Vaccine Genetic Engineering Protein 52

XTalks

SEPTEMBER 15, 2022

The US Food and Drug Administration (FDA) approved the first genetically engineered crops nearly 30 years ago with the Rainbow papaya — created with an immunity to a virus that threatened to decimate the crop — and the Flavr Savr tomato. Biotechnology is also taking on new forms in food. GMO and Bioengineering Controversy.

FDA Approval 95

FDA Approval Genetic Engineering Genetics Production 95

Drug Discovery World

JULY 22, 2022

By Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences. The future could involve creating genetically engineered DCs or “CAR-DC” cells using patient-derived neoantigen-loaded cells to improve clinical outcomes 30. Courtney Ferrebee, PhD, is a field applications scientist at Taconic Biosciences.

In-Vivo 52

In-Vivo Engineer In-Vitro Antibody 52

Drug Discovery World

SEPTEMBER 28, 2022

Scientists from Tel Aviv University have deciphered the mechanism that enables skin cancer to metastasise to the brain and were able to delay the spread of the disease by 60-80% using existing treatments. . Once melanoma, or skin cancer, spreads to the brain, it becomes extremely aggressive. Spread of metastases delayed .

Research 52

Research Gene Editing Genetic Engineering Protein 52

The Pharma Data

JANUARY 24, 2021

25, 2021 /PRNewswire/ — Elasmogen Ltd , the pioneering biopharmaceutical company leading the development of VNAR and soloMER biologics, today announces a significant breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping COVID-19 infections. ABERDEEN, Scotland , Jan.

Antibody 52

Antibody Protein Research Genetic Engineering 52

Drug Discovery World

MARCH 13, 2023

Whereas mature manufacturing systems for biologic drugs start with a consistent source material and use established platform processes, equipment, and analytics, cell therapy development represents just the opposite.  Consider a mature protein therapeutic that’s existed for 30-plus years. Genetic Engineering & Biotechnology News.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

Drug Discovery World

JANUARY 23, 2023

Increasing interest in CRISPR-Cas gene editing systems over recent years has delivered innovative developments in precision genome engineering technologies, holding enormous potential for applications across the healthcare sector. References 1:Thomson J, Itskovitz-Eldor J, Shapiro S, et al.

Gene Editing 52

Gene Editing Gene Engineer DNA 52